Background To discuss the clinicopathological features and prognosis of patients with
idiopathic membranous nephropathy (IMN) who are serum-negative for the anti-PLA2R …

Background Idiopathic membranous nephropathy (IMN) with deposits of phospholipase A2
receptor (PLA2R) antigen in glomerular tissue (GAg+) but no circulating serum PLA2R …

Introduction Primary membranous nephropathy (PMN) is associated with the anti-
phospholipase A2 receptor (anti-PLA2R) antibody in 70% of cases. Some anti-PLA2R …

Background: Anti-phospholipase A2 receptor (PLA2R) antibodies are specific to the
diagnosis of primary membranous nephropathy (pMN). The prevalence of positive …

Background: Idiopathic Membranous Nephropathy (iMN) is the most common cause of
nephrotic syndrome in adults. Approximately one third of patients with iMN progress to end …

Patients with idiopathic membranous nephropathy (IMN) can be categorized into
phospholipase A2 receptor (PLA2R)-associated and non-PLA2R-associated cases …

Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …

Background: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful in diagnosing
idiopathic membranous nephropathy (IMN). We investigated the clinical relevance of PLA2R …

Aim Serum levels of phospholipase A2 receptor antibody (PLA2R; SAb) and glomerular
deposits of PLA2R antigen (GAg) have been detected in patients with idiopathic …